Salt Lake City, Utah
Colorectal cancer clinical trials in Salt Lake City, UT
32 colorectal cancer studies are recruiting participants at sites in Salt Lake City as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Salt Lake City at a glance
- 32 studies are recruiting at a site in Salt Lake City.
- By phase: Phase 1 (7), Phase 1/2 (9), Phase 2 (4), Phase 2/3 (1), Phase 3 (1), No phase (5), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (21), university, hospital or other (11).
- Most recent update to one of these records: November 13, 2026.
Studies recruiting in Salt Lake City
Basic details from each study's public record (the 30 most recently updated of 32). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Huntsman Cancer Institute University of Utah
- Registry record
- NCT07488676 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT07458347 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Huntsman Cancer Institute - University of Utah
- Registry record
- NCT07659795 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07020221 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- George E Wahlen Department of Veterans Affairs Medical Center
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Huntsman Cancer Institute/University of Utah · LDS Hospital · Utah Cancer Specialists-Salt Lake City
- Registry record
- NCT05174169 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Huntsman Cancer Institute/University of Utah
- Registry record
- NCT05673148 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- University of Utah - Huntsman Cancer Institute
- Registry record
- NCT07542704 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study sites
- University of Utah Health Huntsman Cancer Hospital · Utah Cancer Specialists
- Registry record
- NCT03526835 · updated
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06330064 · updated
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT06973564 · updated
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Delcath Systems Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06607458 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07544589 · updated
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- No phase
- Ages 65 to 82
- All sexes
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study site
- University of Utah
- Registry record
- NCT05612347 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06445062 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07020117 · updated
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study site
- Utah Cancer Specialists
- Registry record
- NCT05059444 · updated
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- NSABP Foundation Inc
- Study site
- Huntsman Cancer Institute - University of Utah
- Registry record
- NCT07058012 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- START Mountain Region
- Registry record
- NCT06131840 · updated
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Coherus Oncology, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06657144 · updated
Increasing Germline Genetic Testing for Patients With Cancer
- No phase
- All ages
- All sexes
- Sponsor
- Josh Peterson
- Study site
- University of Utah Health
- Registry record
- NCT07307664 · updated
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Recursion Pharmaceuticals Inc.
- Study site
- Huntsman Cancer Institute and University of Utah
- Registry record
- NCT05552755 · updated
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT06917079 · updated
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT05663502 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT05379985 · updated
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Stanford University
- Study site
- George E. Wahlen Department of Veterans Affairs Medical Center
- Registry record
- NCT05297734 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- START Center for Cancer Care - Mountain Region
- Registry record
- NCT06395519 · updated
Improving Care for Rural Patients With Solid Tumors
- No phase
- Ages 18 to 99
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- Huntsman Cancer Institute at the University of Utah
- Registry record
- NCT04916990 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Ask about studies near Salt Lake City
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections